[1]
Martinon F, Krishnan S, Lenzen G, et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol 1993; 23(7): 1719-22.
[http://dx.doi.org/10.1002/eji.1830230749] [PMID: 8325342]
[http://dx.doi.org/10.1002/eji.1830230749] [PMID: 8325342]
[2]
Kranz LM, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 2016; 534(7607): 396-401.
[http://dx.doi.org/10.1038/nature18300] [PMID: 27281205]
[http://dx.doi.org/10.1038/nature18300] [PMID: 27281205]
[3]
Oberli MA, Reichmuth AM, Dorkin JR, et al. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett 2017; 17(3): 1326-35.
[http://dx.doi.org/10.1021/acs.nanolett.6b03329] [PMID: 28273716]
[http://dx.doi.org/10.1021/acs.nanolett.6b03329] [PMID: 28273716]
[4]
Persano S, Guevara ML, Li Z, et al. Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination. Biomaterials 2017; 125: 81-9.
[http://dx.doi.org/10.1016/j.biomaterials.2017.02.019] [PMID: 28231510]
[http://dx.doi.org/10.1016/j.biomaterials.2017.02.019] [PMID: 28231510]
[5]
Guevara ML, Persano F, Persano S. Advances in lipid nanoparticles for MRNA-based cancer immunotherapy. Front Chem 2020; 8589959
[http://dx.doi.org/10.3389/fchem.2020.589959] [PMID: 33195094]
[http://dx.doi.org/10.3389/fchem.2020.589959] [PMID: 33195094]
[6]
Sahin U, Derhovanessian E, Miller M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 2017; 547(7662): 222-6.
[http://dx.doi.org/10.1038/nature23003] [PMID: 28678784]
[http://dx.doi.org/10.1038/nature23003] [PMID: 28678784]
[7]
Stadler CR, Bähr-Mahmud H, Celik L, et al. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. Nat Med 2017; 23(7): 815-7.
[http://dx.doi.org/10.1038/nm.4356] [PMID: 28604701]
[http://dx.doi.org/10.1038/nm.4356] [PMID: 28604701]
[8]
Hotz C, Wagenaar TR, Gieseke F, et al. Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models. Sci Transl Med 2019; 13(610)abc7804
[http://dx.doi.org/10.1126/scitranslmed.abc7804]
[http://dx.doi.org/10.1126/scitranslmed.abc7804]
[9]
de Alwis R, Gan ES, Chen S, et al. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice. Mol Ther 2021; 29(6): 1970-83.
[http://dx.doi.org/10.1016/j.ymthe.2021.04.001] [PMID: 33823303]
[http://dx.doi.org/10.1016/j.ymthe.2021.04.001] [PMID: 33823303]
[10]
Erasmus JH, Archer J, Fuerte-Stone J, et al. Intramuscular delivery of replicon RNA encoding ZIKV-117 human monoclonal antibody protects against zika virus infection. Mol Ther Methods Clin Dev 2020; 18: 402-14.
[http://dx.doi.org/10.1016/j.omtm.2020.06.011] [PMID: 32695842]
[http://dx.doi.org/10.1016/j.omtm.2020.06.011] [PMID: 32695842]
[11]
Guevara ML, Jilesen Z, Stojdl D, Persano S. Codelivery of mRNA with α-galactosylceramide using a new lipopolyplex formulation induces a strong antitumor response upon intravenous administration. ACS Omega 2019; 4(8): 13015-26.
[http://dx.doi.org/10.1021/acsomega.9b00489] [PMID: 31460428]
[http://dx.doi.org/10.1021/acsomega.9b00489] [PMID: 31460428]
[12]
Persano F, Gigli G, Leporatti S. Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions. Nano Express 2021; 2012006
[http://dx.doi.org/10.1088/2632-959X/abeb4b]
[http://dx.doi.org/10.1088/2632-959X/abeb4b]
Article Metrics
14
1